The Food and Drug Administration has approved Tocilizumab for use against moderate to severe Covid-19 symptoms.
New Monoclonal Antibody Fully Approved For The Treatment Of Covid-19
The Food and Drug Administration has approved Tocilizumab for use against moderate to severe Covid-19 symptoms.